Gilead Sciences, Inc.'s Veklury (remdesivir) is the first and only drug approved by the US Food and Drug Administration for the treatment of COVID-19, although it is already widely used for treating the infection in hospitalized patients. Veklury was granted an emergency use authorization in May for the treatment of patients with COVID-19 requiring hospitalization. (Also see "Gilead Sets Remdesivir Price, Commits Nearly All Near-Term Supplies To US" - Scrip, 30 June, 2020.)
The antiviral was one of the first options to become available to patients hospitalized with COVID-19, along with the steroid...
